S100A8 and brucellosis: These results indicate that brucellosis patients at the acute stage exhibited S100A8/A9‐TLR4‐inflammatory traits, highlighting the significance of S100A8/A9 for developing effective therapeutic approaches to mitigate immunopathogenesis in acute brucellosis patients.